Tekmira Pharmaceuticals Corporation Announces Third Quarter 2009 Operating Results and Provides Corporate Update
11/13/2009 10:03:15 AM
More...
|
Tekmira Pharmaceuticals Corporation Conference Call Advisory
11/10/2009 11:20:22 AM
More...
|
Tekmira Pharmaceuticals Corporation to Webcast Presentation at the Rodman & Renshaw Global Investment Conference
9/9/2009 12:50:16 PM
More...
|
Tekmira Pharmaceuticals Corporation Announces Second Quarter 2009 Operating Results and Provides Corporate Update
8/12/2009 9:57:23 AM
More...
|
Tekmira Pharmaceuticals Corporation Conference Call Advisory; Second Quarter 2009 Operating Results and Corporate Update
8/7/2009 12:36:33 PM
More...
|
Alnylam Pharmaceuticals (ALNY) and Tekmira Pharmaceuticals Corporation Participate in New Research Collaboration
8/6/2009 6:40:25 AM
More...
|
Tekmira Pharmaceuticals Corporation Initiates ApoB SNALP Phase 1 Clinical Trial
7/6/2009 10:54:02 AM
More...
|
Tekmira Pharmaceuticals Corporation Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference
5/28/2009 10:31:48 AM
More...
|
Strong Immune Response To New siRNA Drugs In Development May Cause Toxic Side Effects, Tekmira Pharmaceuticals Corporation Study
5/20/2009 8:33:33 AM
More...
|
Tekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update
5/13/2009 11:13:33 AM
More...
|
|